For Highmark BCBS members from Pennsylvania, West Virginia, Delaware, or parts of New York traveling to California for substance-use treatment. Highmark is one of the largest independent BCBSA licensees, and Highmark members access non-Highmark facilities through BlueCard PPO reciprocity. We verify your Highmark benefits, file prior authorization with Highmark’s Behavioral Health Choice (PA) or equivalent regional UM, and advocate through state-specific external appeals.
In most cases, yes. Highmark Inc. is one of the largest independent BCBSA licensees, covering Pennsylvania, West Virginia, Delaware, and parts of upstate New York under different regional sub-brands (Highmark BCBS PA, Highmark Health Options DE, Highmark BCBS WV, Highmark BCBS NY). Highmark members traveling to California for treatment access non-Highmark facilities through the BlueCard PPO reciprocity network — claims route to your home Highmark plan for adjudication while care is delivered locally. Most Highmark plans cover medical detox, residential treatment, MAT, partial hospitalization, intensive outpatient, and structured aftercare. Our utilization-review team verifies your home Highmark plan benefits and BlueCard cost-sharing for treatment in California.
If your card lists Highmark, Highmark BCBS, Highmark Blue Shield, or Highmark Health Options, this is the verification path that applies to you. For BCBS members from other states (Anthem BCBS NY, BCBS Texas, Florida Blue, etc.), see our general BCBS BlueCard page.
Highmark’s behavioral-health utilization management runs through Highmark Behavioral Health Choice (in PA) or equivalent regional UM teams in WV, DE, and NY. The BlueCard PPO out-of-state framework standardizes most authorization decisions across regions. Typical authorization windows we see:
Specific authorization length depends on your home Highmark region’s plan rules, the clinical assessment at intake, and concurrent-review decisions Highmark’s UM team makes during your stay. Medical necessity is documented in clinical language at every concurrent-review window.
Authorization tells you what’s covered; the program decides whether it works. Highmark members traveling from PA, WV, DE, or NY to California are evaluating both insurance fit and clinical depth at the same time — they’re looking for a treatment center that handles the BlueCard cross-region paperwork without dropping the clinical work.
Coverage is the door; the clinical work happens after you walk through it.
Highmark’s BlueCard out-of-state framework routes claims and utilization decisions back to your home Highmark plan — the local BCBS plan in California (Anthem BC) facilitates the claims handoff but Highmark’s own UM team makes the authorization decisions. Our utilization-review and billing team handles the BlueCard cycle directly with Highmark.
The decision to escalate is not commercial. It’s clinical. When a client is denied care that’s clinically indicated, we advocate for them — through every step above — to support coverage of the level of care our team believes is medically appropriate.
Highmark coverage is governed by federal law plus the specific insurance law of your home Highmark region.
When we appeal a Highmark denial, the appeal is built on the clinical documentation, federal MHPAEA, and the specific home-state insurance law applicable to your plan. All three matter.
“28 days” is an insurance number, not a clinical number. The research has been pointing somewhere else for decades. The National Institute on Drug Abuse, summarizing decades of research in its Principles of Effective Treatment, states that participation in treatment for less than 90 days is of limited effectiveness for most substance-use disorders, and that better outcomes are associated with longer durations of treatment.
This is why we build for length-of-stay flexibility. Some Highmark members need a focused inpatient stay because of work, family, or operational constraints back in the home region, then continue at PHP or IOP. Others — those with severe withdrawal risk, complex psychiatric comorbidity, or chronic relapse history — need extended residential care.
When concurrent review tries to cut a stay short, our UR and medical teams document the clinical reasoning, file the peer-to-peer request, and pursue appeals — including the home-state external-review pathway — when warranted.
Highmark Inc. covers a substantial population across the mid-Atlantic. Some of the populations whose plans we commonly verify:
If your card lists Highmark with any regional sub-brand, our UR team can identify your home Highmark plan from the alpha prefix and walk through the verification with you.
Three steps. No commitment.
In most cases, yes. Highmark members from PA, WV, DE, or NY access California treatment through the BlueCard PPO reciprocity network. Cost-sharing depends on your home Highmark region’s plan rules and BlueCard out-of-network rates. Our UR team verifies the specifics for your home region before admission.
Behavioral Health Choice is Highmark’s behavioral-health utilization management unit in Pennsylvania. It handles prior authorization, concurrent review, and peer-to-peer reviews for SUD and mental-health services for PA Highmark members. Equivalent regional UM teams handle the same role for WV, DE, and NY Highmark members.
PA Act 106 (1989) is one of the oldest state-level mental-health and substance-use parity laws in the US. It requires commercial group health plans to cover SUD treatment with parity to medical benefits, predating federal MHPAEA by nearly 20 years. PA Highmark members benefit from Act 106’s enforceable coverage rights and strong external-appeals pathway through the PA Insurance Department.
Most Highmark plans cover medical detox when medically indicated. Authorization windows we typically see are 3 to 14 days, depending on substance, withdrawal severity, and medical complexity.
Most Highmark plans require prior authorization for medical detox and residential admission, regardless of where treatment is received. Our UR team files the prior-auth request with your home Highmark region’s UM team using their specific submission requirements.
Our medical director conducts a peer-to-peer review with Highmark’s medical director. If the denial holds, we file Level-1 and Level-2 internal appeals with the home-state framework — citing Act 106 for PA members, and equivalent state laws for WV, DE, and NY. When internal appeals are exhausted, we handle external appeals through the appropriate state insurance regulator’s external-review program.
Most Highmark plans cover MAT for opioid use disorder (buprenorphine, naltrexone) and alcohol use disorder (naltrexone, acamprosate) when prescribed as part of a clinical treatment plan. Highmark’s prescription benefit covers most standard MAT formulary lines.
Most Highmark plans cover treatment of co-occurring psychiatric conditions alongside substance-use treatment per federal MHPAEA parity requirements and home-state coverage law (PA Act 106 in particular requires explicit dual-diagnosis coverage parity).
One call. Our UR team handles the Highmark BlueCard verification end-to-end and reports back. Verification is free, confidential, and not a commitment to admit.
All Highmark, Highmark BCBS, Highmark Health Options, and BlueCard trademarks remain with their owners. This page exists to explain coverage, not to claim affiliation. Insurance acceptance is subject to benefit verification. Treatment outcomes vary by individual; statements about the authorization, peer-to-peer, and appeals process describe Gev’s Recovery’s standard practices and do not guarantee specific coverage decisions by your plan. Gev’s Recovery Center · 19448 Lassen St, Northridge, CA 91324 · CA DHCS license #191288AP.